Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis
- 29 February 2004
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 111 (2), 352-356
- https://doi.org/10.1016/s0161-6420(03)00721-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Safety and efficacy of TNFalpha blockade in relapsing vasculitisAnnals Of The Rheumatic Diseases, 2002
- Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexateBritish Journal of Dermatology, 2001
- Neutralizing TNF-alpha Activity Modulates T-cell Phenotype and Function in Experimental Autoimmune UveoretinitisJournal of Autoimmunity, 1998
- Cytokines: Their role in uveal diseaseEye, 1997
- The possible impact of uveitis in blindness: a literature survey.British Journal of Ophthalmology, 1996
- New concepts on the role of autoimmunity in the pathogenesis of uveitisEye, 1992
- Cytokines and uveitis, a reviewCurrent Eye Research, 1992
- Uveitis and systemic disease.British Journal of Ophthalmology, 1992
- Uveitis: pathogenesisThe Lancet, 1991
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989